{
  "html": "<table border=\"1px\" style=\"width: 100%;\"> <tbody><tr><td>&nbsp;</td>\n\t\t\t\t\t<th>PC Number</th>\n\t\t\t\t\t<th>Date</th>\n\t\t\t\t\t<th>Chapter</th>\n\t\t\t\t\t<th>Bill</th>\n\t\t\t\t\t<th>Dept</th></tr><tr><td style=\"min-width: 120px;\">&nbsp;</td><td>2020-0413</td><td>2020-05-30</td><td></td><td></td><td>,&nbsp; ,&nbsp; ,&nbsp; HC,&nbsp; ,&nbsp; ,&nbsp; </td></tr><tr><td>Act</td><td colspan=\"5\">Patent Act</td></tr><tr><td>Subject</td><td colspan=\"5\">Regulations Amending the Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements)</td></tr><tr><td>Precis</td><td colspan=\"5\" id=\"precis\">Regulations Amending the REGULATIONS AMENDING THE PATENTED MEDICINES REGULATIONS (ADDITIONAL FACTORS AND INFORMATION REPORTING REQUIREMENTS) in order to delay the coming-into-force of the Amending Regulations until January 1, 2021 (1) to minimize the imposition of new administrative burden on industry as patented drug manufacturers face increased demands related to supply chains and shortages of existing products and, potentially, new treatments and vaccines in response to COVID-19; and (2) to provide stakeholders a longer period in which to provide feedback to the Patented Medicine Prices Review Boardâ€™s Guidelines consultation process, which has been impacted by the COVID-19 pandemic.</td></tr><tr><td>Registration</td><td colspan=\"5\" id=\"registration\"><strong>Registration: </strong>SOR/ 2020-0126  <strong>Publication Date:</strong> 2020-06-10</td></tr><tr><td>Attachments</td><td colspan=\"5\"><a href=\"attachment.php?attach=39339&amp;lang=en\">Attachment</a></td></tr></tbody></table>",
  "pcNumber": "2020-0413",
  "htmlHash": "a8d68950696f3dfa8f4c4c5199dfc48f",
  "attachments": [
    "39339"
  ]
}